Move to Live®More
A podcast series featuring thought leaders in healthcare, health and fitness, and communities. We address solutions for chronic disease, obesity and physical inactivity through cross-sector collaboration and innovation.
Show episodes
An interview with Elaine Economou, Co-Founder and CEO of MOVE Wellness. I used to say that people were coming for a six pack, and I was teaching them how to be mindful and more self-aware. Elaine Economou Inspiration for entering the health & fitness industry Supporting clients through their whole health journey Move
An interview with Chris Powell, Founder of Move One Million. It"s people around the world, and there"s every race and there"s every religion, and there"s every political preference, and there"s, it is fully inclusive, because in movement and in humanity, that"s, we see through all of it. There is no, when you"re doing
Leading with Science When Supporting Lifestyle Change in Patients Taking Obesity Medications
An interview with Dr. Renee Rogers and Dr. Michael Hosking. If you don"t know the answer to something, it"s okay to say you don"t know the answer to something and that you"ll look into it. And I think that"s a really important space for building trust with your patients. Dr. Renee Rogers I would say to the boots on the
An interview with Ross Stewart Campbell, Founder and CEO of Beyond Activ. I think only in the past five years have we really made true strides in becoming a technology-enabled, data-led, outcomes-driven industry, and with that short window of maturity, I don"t think we can beat ourselves up too much that we haven"t ach
An interview with Dr. Chloë Williamson, Lecturer at the University of Edinburgh. We"re not rational, and the guidelines and the way they"re traditionally messaged and have been messaged assumes that humans are rational and that they"ll do things that they know is good for them. But in actual fact, your day to day behav
An interview with Dr. Kathryn Schmitz, Interim Director of the UPMC Hillman Cancer Center. We have one randomized control trial showing, in one group of cancer patients, that there is a disease free survival benefit and a mortality benefit, and we know that there"s a lot of nice to have outcomes, right? Nice, nice to h